Cancer and comorbidity in older patients: A descriptive profile

Annals of Epidemiology

Volumn 6, Issue 5, 1996, Pages 399-412

  Yancik, Rosemary ^a   Havlik, Richard J ^a   Wesley, Margaret N ^b   Ries, Lynn ^c   Long, Sherrill ^b   Rossi, Winifred K ^a   Edwards, Brenda K ^c  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b INFORMATION MANAGEMENT SERVICES INC   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

aging; Cancer; comorbidity; elderly

Indexed keywords

ADULT; AGED; AGING; ARTHRITIS; ARTICLE; CANCER; CANCER INCIDENCE; CANCER RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

AGE DISTRIBUTION; AGED; COMORBIDITY; FEMALE; GERIATRIC ASSESSMENT; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; SEER PROGRAM; SEVERITY OF ILLNESS INDEX; SEX FACTORS; UNITED STATES;

EID: 0030248903     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(96)00063-4     Document Type: Article

References (40)

1. 1. US Senate Special Committee on Aging, American Association of Retired Persons, Federal Council on Aging, US Administration on Aging. Aging America: Trends and Projections. Washington DC: US Department of Health and Human Services; 1991.
2. 2. Brocklehurst JC, Hanley T. Geriatric Medicine for Students. New York: Churchill Livingstone; 1976.
3. 3. Verbrugge LM, Lepkowski JM, Imanaka Y. Comorbidity and its impact on disability, Milbank. 1989;67:450-484.
4. 4. Yancik R, Ries LG, Yates JW. Ovarian cancer in the elderly: An analysis of surveillance, epidemiology, and end results program data. Am J Obstet Gynecol. 1986;154:639-647.
5. 5. Yancik R, Ries LG. Caring for elderly cancer patients. Cancer. 1989;(Suppl);64:335-341.
6. 6. Celentano DD. Early detection of cervical cancer in elderly women. In: Yancik R, Yates JW, eds. Cancer in the Elderly: Approaches to Early Detection and Treatment. New York: Springer Publishing Company; 1989;15-27.
7. 7. Havlik RJ, Yancik R, Long S, Ries L, Edwards B. The National Institute on Aging and the National Cancer Institute SEER collaborative study on comorbidity and early diagnosis of cancer in the elderly. Cancer. 1994;(Suppl);74:2101-2106.
8. 8. American Joint Committee on Cancer. Manual for Staging of Cancer. 3rd ed. Philadelphia:Lippincott; 1992.
9. 9. Ries LAG, Miller BA, Hankey BF, Kosary CL, Harras A, Edwards BK, eds. SEER Cancer Statistics Review, 1973-1991: Tables and Graphs, National Cancer Institute. NIH Publication. No. 94-2789. Bethesda, MD: National Institute of Health; 1994.
10. 10. Mantel N. Chi-square tests with one decree of freedom: extensions of Mantel-Haenszel procedure. Am Stat Assoc. 1963;58:690-700.
11. 11. Klein BE, Moss SE, Klein R. Use of cardiovascular disease medications and mortality in people with older onset diabetes. Am J Public Health. 1992;82:1145-1147.
12. 12. Benson V, Marano MA. Current Estimates from the National Health Interview Survey. Washington DC: National Center for Health Statistics; 1994.
13. 13. Epstein JI, Walsh PC, Brendler CB. Radical prostatectomy for impalpable prostate cancer: The Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1R) and on needle biopsy (stage T1C), J Urol. 1994;152:1721-1729.
14. 14. Severson RK. Have transurethral resections contributed to the increasing incidence of prostate cancer? J Natl Cancer Inst. 1990;82: 1597-1598.
15. 15. Potosky AL, Kessler L, Gridley G et al. Rise in prostatic cancer incidence associated with increased use of transurethral resection. J Natl Cancer Inst. 1990;82:1624-1628.
16. 16. Holmes FF, Hearne E III. Cancer stage-to-age relationship: implications for cancer screening in the elderly. J Am Geriatr Soc. 1981;29:55-57.
17. 17. Mor V, Masterson-Allen S, Goldberg RJ, Cummings FJ, Glicksman AS, Fretwell MD. Relationship between age at diagnosis and treatments received by cancer patients. J Am Geriatr Soc. 1985;33:585-589.
18. 18. Goodwin JS, Samet JM, Key CR, Humble CG, Kutvirt D, Hunt C. Stage at diagnosis of cancer varies with the age of the patient. J Am Geriatr Soc. 1986;34:20-26.
19. 19. Boult C, Kane RL, Louise TA, Boult L, McCaffrey D. Chronic conditions that lead to functional limitation in the elderly. J Gerontol: Med Sci. 1994;49;M28-M36.
20. 20. Furner SE, Rudberg MA, Cassel CK. Medical conditions differentially affect the development of IADL disability: implications for medical care and research. Gerontologist. 1995;35:444-450.
21. 21. Guccione AA, Felson DT, Anderson JJ, et al. The effects of specific medical conditions on the functional limitations of elders in the Framingham study. Am J Public Health. 1994;84:351-358.
22. 22. Charlson ME. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chron Dis. 1987;40:373-383.
23. 23. Greenfield S, Blanco DM, Elashoff RM, Ganz PA. Patterns of care related to age of breast cancer patients. JAMA. 1987;257:2766-2770.
24. 24. Iezzoni LI, Moskowitz MA. A clinical assessment of MedisGroups. JAMA. 1988;260:3159-3163.
25. 25. Horn SD. Measuring severity of illness: Comparisons across institutions. Am J Public Health. 1983;73:25-31.
26. 26. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: A severity of disease classification system. Crit Care Med. 1985; 13:818-829.
27. 27. Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991;100:1619-1636.
28. 28. Wagner D, Draper E, Knaus W. APACHE III study design: analytic plan for evaluation of severity and outcome in intensive care unit patients. Development of APACHE III. Crit Care Med. 1989;17:S199-S203.
29. 29. Greenfield S, Aronow HU, Elashoff RM, Ganz PA. Flaws in mortality data: The hazards of ignoring comorbid disease. JAMA. 1988; 260:2253-2255.
30. 30. Iezzoni LI, Ash AS, Coffman G, Moskowitz MA. Predicting in-hospital mortality: A comparison of severity measurement approaches. Med Care. 1992;30:347-359.
31. 31. Iezzoni LI, Heeren T, Foley SM, Daley D, Hughes J, Coffman GA. Chronic conditions and risk of in-hospital death. Health Ser Res. 1994;29:435-460.
32. 32. Charlson ME. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data. A response. J Clin Epidemiol. 1993;46: 1083-1084.
33. 33. Deyo RA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619.
34. 34. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectives. J Clin Epidemiol. 1993;46:1075-1079.
35. 35. Satariano WA, Ragheb NE, Dupuis M. Comorbidity in older women with breast cancer: An epidemiologic approach. In: Yancik R, Yates JW, eds. Cancer in the Elderly: Approaches to Early Detection and Treatment. New York: Springer; 1989:71-107.
36. 36. Satariano WA. Aging, comorbidity, and breast cancer survival: an epidemiologic view. In: Yang SS, Warner HR. eds. The Underlying Molecular, Cellular, and Immunological Factors in Cancer and Aging. New York: Plenum Press; 1993:1-11.
37. 37. Yancik R, Ries LG. Cancer in older persons: Magnitude of the problem - how do we apply what we know? Cancer. 1994 (Suppl);74: 1995-2003.
38. 38. Spencer G. Projections of the Population of the United States, by Age, Sex and Race: 1988 to 2080. U.S. Bureau of the Census, Current Population Reports, P25-1018. Washington, DC: U.S. Government Printing Office; 1993.
39. 39. Day JC. Population Projections of the United States, by Age, Sex, Race, and Hispanic Origin: 1993-2050. U.S. Bureau of the Census, Current Population Reports, P25-1104. Washington, DC: U.S. Government Printing Office; 1993.
40. 40. Polednak, AP. Projected numbers of cancers diagnosed in the US elderly population, 1990 through 2030. Am J Public Health. 1994; 84:1313-1316.